Abstracts tagged "giant cell arteritis and positron emission tomography (PET)"

Abstract Number: L15 • 2018 ACR/ARHP Annual Meeting
The Diagnostic Accuracy of PET/CT Scan of the Head, Neck and Thorax Compared with Temporal Artery Biopsy in Patients Newly Suspected of Having GCA
Anthony Sammel¹, Edward Hsiao², Geoffrey Schembri³, Katherine Nguyen⁴, Janice Brewer⁴, Leslie Schrieber⁵, Beatrice Janssen⁴, Peter Youssef⁶, Clare Fraser⁷, Elizabeth Bailey⁸, Dale Bailey⁸, Paul Roach⁸ and Rodger Laurent⁴, ¹Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia, ²Royal North Shore Hospital, St Leonards, Australia, ³Nuclear Medicine, Royal North Shore Hospital, St Leonards, Australia, ⁴Royal North Shore Hospital, St Leonards, Sydney, Australia, ⁵Northern Clinical School, University of Sydney, Sydney, Australia, ⁶Royal Prince Alfred Hospital, Camperdown, Sydney, Australia, ⁷Save Sight Institute, Sydney, Australia, ⁸Royal North Shore Hospital, Sydney, Australia
Background/Purpose: The diagnostic accuracy of PET/CT against temporal artery biopsy (TAB) in patients suspected of having GCA has not been well studied. PET/CT has traditionally…
Abstract Number: 262 • 2017 ACR/ARHP Annual Meeting
FDG PET/CT Visualization of Inflammation in Temporal and Maxillary Arteries in Treatment-Naive GCA Patients
Berit Dalsgaard Nielsen^1,2, Ib Tønder Hansen^3,4, Kresten Krarup Keller⁵, Philip Therkildsen^6,7, Ellen-Margrete Hauge^6,8 and Lars Christian Gormsen⁹, ¹Rheumatology, Department of Rheumatology, Aarhus University Hospital, Århus C, Denmark, ²Clnical Medicine, Department of Clinical Medicine, Aarhus University Hospital, Århus N, Denmark, ³Clinical Medicine, Department of Clinical Medicine, Aarhus University Hospital, Århus N, Denmark, ⁴Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, ⁵Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, ⁶Clinical medicine, Department of Clinical Medicine, Aarhus University Hospital, Århus N, Denmark, ⁷Department of Rheumatology, Aarhus University Hospital, Aarhus C, Denmark, ⁸Department of Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, ⁹Nuclear Medicine and PET Center, Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Århus C, Denmark
Background/Purpose: Fluorine-18-fluorodeoxyglucose (FDG) PET/CT is increasingly used to diagnose large vessel GCA (LV-GCA), but has previously been considered unable to reveal inflammation in temporal arteries…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].